A 44-week Monocentric Open Study Assessing the Efficacy and Safety of Deucravacitinib in Adults With Inflammatory Genodermatoses

Abroad (travel likely)RecruitingPHASE2

Conditions

Epidermolysis Bullosa Simplex · Ichthyosis · Genodermatosis · Inflammatory Congenital Ichthyoses

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

CHU de Nice, Nice, CHU de NICE, France
Study coordinator · 0492034702
Contact: Principal Investigator (Christine CHIAVERINI)
APHP St Louis, Paris, France, France
Contact: Study coordinator (Emmanuelle BOURRAT, Doctor) · marioncauseret@yahoo.fr · 01 42 49 45 41
Contact: Principal Investigator (Emmanuelle BOURRAT, Doctor)

Study leads

Christine Chiaverini
Principal Investigator
Centre Hospitalier Universitaire de Nice

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A 20-Week Study Assessing the Efficacy of Apremilast in Patients with EB Simplex Generalized

Epidermolysis Bullosa Simplex · Genodermatosis

Abroad (travel likely)RecruitingPHASE2

Nice, France · Paris, France

A Phase II, Placebo Controlled, Clinical Trial of Topical TolaSure Targeting Aggregated Mutant Keratin in Epidermolysis Bullosa Simplex

Epidermolysis Bullosa Simplex

Abroad (travel likely)RecruitingPHASE2

Palo Alto, United States · Chicago, United States